Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAvingtrans Regulatory News (AVG)

Share Price Information for Avingtrans (AVG)

Share Price is delayed by 15 minutes
Get Live Data
652.00    0.00 (0.00%)
Bid:
644.00
Ask:
660.00
Spread: 16.00 (2.484%)
Market Cap: £219.22m
AVG Live PriceLast checked at - London Stock Exchange

Intraday Avingtrans Share Chart

New Contract Win and Framework Agreements

15 Feb 2016 07:00

RNS Number : 9924O
Avingtrans PLC
15 February 2016
 

15 February 2016

Avingtrans Plc

("Avingtrans" or the "Company" or the "Group")

 

New Contract and Framework Agreements for Energy and Medical Division

 

Avingtrans (AIM:AVG), which designs, manufactures and supplies critical components, modules and associated services to the aerospace, energy and medical sectors is pleased to announce that its Energy and Medical division has diversified into the materials technology market, with a contract to provide composite components for airport scanners.

 

Avingtrans has signed an initial contract and three-year framework agreement worth over £3.5 million with Rapiscan, a leading security screening provider based in California. Under the terms of the contract, Avingtrans will provide key components for Rapiscan's new and ground-breaking airport scanner, the RTT110 (Real Time Tomography). The RTT110 is also the first scanner to successfully pass the European Civil Aviation Conference's (ECAC) Standard 3 threat detection test for baggage-borne explosive risks - a standard that will become compulsory for airports around the world by 2020.

 

Additionally, Avingtrans is also pleased to announce that Stainless Metalcraft, also part of the Group's Energy and Medical division, has signed a framework agreement with Bruker BioSpin AG ("Bruker"), a Swiss based market leader in analytical magnetic resonance instruments. Production will initially take place in the UK, before manufacturing transitions to Metalcraft's own established facility in Chengdu, China. Worth £1m per annum, the agreement will see Stainless Metalcraft produce high integrity cryostat components for Bruker's Nuclear Magnetic Resonance systems (NMR). NMR spectroscopy complements other structural and analytical techniques, such as X-ray, crystallography and mass spectrometry and can be used alongside MRI related technology, to provide multidimensional images and spatially resolved information.

 

Austen Adams, Managing Director of Avingtrans' Energy & Medical division, said: "We are delighted to announce these important new work programmes with Rapiscan and Bruker. Both mark an important development in the ongoing diversification of the Energy and Medical division"

 

"We have been working with Rapiscan to develop its RTT110 scanner for a some time now and this supply contract means we can now ramp up production to meet fast-growing demand. Security is a real challenge for airports as passenger numbers increase around the world but, until now, this increase has not been matched by advances in security risk detection technology."

 

"We will work closely with Bruker to develop a fully value-engineered solution for the components for their NMR programmes, ensuring all procedures and processes are firmly established, before transitioning the work to our Chinese site, which will not only bring additional cost efficiency but also bring the manufacturing closer to end customer locations."

 

 

Enquiries:

 

Avingtrans plc

Steve McQuillan, Chief Executive Officer

Stephen King, Chief Financial Officer

 

Tel: 01159 499 020

Numis

David Poutney (Corporate Broking)

Richard Thomas (Corporate Finance and Nominated Adviser)

 

Tel: 0207 260 1000

Newgate (Financial PR)

Adam Lloyd

Ed Treadwell

Tel: 020 7653 9850

 

 

 

About Avingtrans

 

Avingtrans plc is engaged in the provision of highly engineered components, modules and services to the Aerospace, Energy and Medical markets worldwide.

 

The business is made up of two divisions

 

Aerospace, engaged in the manufacture of rigid pipe assemblies, fabrications and prismatic components - both metallic and composite - for the global aerospace market and precision polishing of aircraft components and;

 

Energy and Medical, engaged in the design and manufacture of machined and fabricated pressure and vacuum vessels and process plant and equipment for the power, oil & gas and medical markets. Plus, design and manufacture of fabricated poles and cabinets for roadside safety cameras and rail track signalling.

 

 

About Rapiscan

 

Rapiscan is a global leading security screening provider, manufacturing a variety of products, solutions and services to meet a variety of threat detection needs both for governments and the private sector. Rapiscan is a wholly-owned subsidiary of OSI Systems (NASDAQ:OSIS) and is headquartered in California with additional offices and manufacturing in Finland, India, Malaysia, Singapore, United Kingdom and the United States. Rapiscan specialises in Baggage and Parcel Inspection, Cargo and Vehicle Inspection, Hold Baggage Screening, People Screening, Screening as Service, Total Security Solutions Provider, Radiation Detection and Trace Detection.

 

 

About Brucker BioSpin AG

 

Bruker Corporation is a US based manufacturer of analytical and medical instruments covering NMR, ESR, FT-IR, X-RAY spectroscopy. Brucker BioSpin, the magnetic resonance division of the Corporation, provides a global leading range of magnetic NMR and EPR spectroscopy and preclinical MRI research tools. The Bruker BioSpin Group of companies develop, manufacture and supply technology to research establishments, commercial enterprises and multi-national corporations across countless industries and fields of expertise.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCQLLFFQLFEBBE
Date   Source Headline
19th May 202610:20 amRNSHolding(s) in Company
14th May 202612:26 pmRNSHolding(s) in Company
12th May 20267:00 amRNSAdaptix receives CE Certification
6th May 20264:28 pmRNSHolding(s) in Company
30th Apr 20262:42 pmRNSHolding(s) in Company
30th Apr 20262:41 pmRNSExercise of Options & TVR
24th Apr 20262:54 pmRNSHolding(s) in Company
16th Apr 20267:00 amRNSStrong Nuclear Orders for Avingtrans
26th Mar 20267:00 amRNS-RScientific Magnetics Ships 20th Quantum Magnet
4th Mar 20267:00 amRNSHolding(s) in Company
25th Feb 20267:00 amRNSInterim Results
12th Feb 202611:49 amRNSHolding(s) in Company
6th Feb 202610:24 amRNSHolding(s) in Company
27th Jan 20265:42 pmRNSExercise of Options & TVR
21st Jan 20267:00 amRNSTrading Update and Notice of Results
12th Jan 20265:13 pmRNSIssue of Share Options
12th Jan 20267:00 amRNS-RMedical & Industrial Imaging Division Appointment
8th Dec 20252:34 pmRNSNotification of Major Holdings
27th Nov 20251:59 pmRNSResult of AGM - Board Appointment
14th Nov 20258:38 amRNSExercise of Options & PDMR Dealings
10th Nov 20257:00 amRNSAdaptix receives FDA 510(K) clearance
1st Oct 20254:52 pmRNSExercise of Options & Total Voting Rights
1st Oct 20253:32 pmRNSHolding(s) in Company
29th Sep 20257:00 amRNSAppointment of Medical Division CEO
24th Sep 20257:00 amRNSPreliminary results for the year ended 31 May 2025
11th Sep 20258:00 amRNSHolding(s) in Company
2nd Sep 20257:00 amRNSHayward Tyler Secures $16m Nuclear Contracts
28th Aug 20257:00 amRNSBooth Industries secures £8.5m HS2 & TfL contracts
25th Jun 20257:00 amRNSTrading Update and Notice of Results
28th May 20257:00 amRNSTrading Update
26th Feb 20257:00 amRNSInterim Results
13th Feb 20257:00 amRNSBooth Industries secures £4.5m Contract
16th Jan 20257:00 amRNSTrading Update & Notice of Results
21st Nov 20244:09 pmRNSResult of AGM
24th Oct 20249:07 amRNSHolding(s) in Company
25th Sep 20247:00 amRNSPreliminary results for the year ended 31 May 2024
3rd Jul 20247:00 amRNSPDMR Dealings
19th Jun 20247:00 amRNSTrading Update and Notice of Results
26th Mar 202411:15 amRNSPDMR Dealings
21st Mar 20245:15 pmRNSExercise of Options, PDMR Dealings & TVR
20th Mar 20243:39 pmRNSHolding(s) in Company
4th Mar 20246:10 pmRNSPDMR Dealings
28th Feb 20247:00 amRNSInterim Results
18th Jan 20247:00 amRNSTrading Update and Notice of Results
15th Dec 20233:00 pmRNSExercise of Options & TVR
4th Dec 20237:00 amRNSMagnetica Limited appoints US distributor
22nd Nov 20237:00 amRNSEmployee & PDMR Share Incentive Awards
16th Nov 20232:20 pmRNSResult of AGM
13th Nov 20237:00 amRNSHayward Tyler Contract Win
11th Oct 20237:00 amRNSContract Wins

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.